|
US7198919B1
(en)
|
1983-04-25 |
2007-04-03 |
Genentech, Inc. |
Use of alpha factor sequences in yeast expression systems
|
|
US4569794A
(en)
|
1984-12-05 |
1986-02-11 |
Eli Lilly And Company |
Process for purifying proteins and compounds useful in such process
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5279833A
(en)
|
1990-04-04 |
1994-01-18 |
Yale University |
Liposomal transfection of nucleic acids into animal cells
|
|
US5439829A
(en)
|
1991-01-30 |
1995-08-08 |
Eli Lilly And Company |
Immobilization of biologically active molecules by changing the Oxidation state of a chelated transition metal ion
|
|
CA2113990A1
(en)
|
1991-07-26 |
1993-02-18 |
Frederick L. Moolten |
Cancer therapy utilizing malignant cells
|
|
US5283185A
(en)
|
1991-08-28 |
1994-02-01 |
University Of Tennessee Research Corporation |
Method for delivering nucleic acids into cells
|
|
IL104570A0
(en)
|
1992-03-18 |
1993-05-13 |
Yeda Res & Dev |
Chimeric genes and cells transformed therewith
|
|
US5320663A
(en)
|
1992-07-02 |
1994-06-14 |
E. I. Du Pont De Nemours And Company |
Method of obtaining lead and organolead from contaminated media using metal accumulating plants
|
|
US5334761A
(en)
|
1992-08-28 |
1994-08-02 |
Life Technologies, Inc. |
Cationic lipids
|
|
WO1995002698A1
(en)
|
1993-07-12 |
1995-01-26 |
Life Technologies, Inc. |
Composition and methods for transfecting eukaryotic cells
|
|
US5631236A
(en)
|
1993-08-26 |
1997-05-20 |
Baylor College Of Medicine |
Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk
|
|
US5650234A
(en)
|
1994-09-09 |
1997-07-22 |
Surface Engineering Technologies, Division Of Innerdyne, Inc. |
Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
US8921528B2
(en)
|
2004-06-01 |
2014-12-30 |
Domantis Limited |
Bispecific fusion antibodies with enhanced serum half-life
|
|
JP2008501706A
(ja)
|
2004-06-04 |
2008-01-24 |
ジェネンテック・インコーポレーテッド |
疾患の治療方法
|
|
EP3530736A3
(en)
|
2005-05-09 |
2019-11-06 |
ONO Pharmaceutical Co., Ltd. |
Human monoclonal antibodies to programmed death 1 (pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics
|
|
KR101704734B1
(ko)
|
2005-07-01 |
2017-02-09 |
이. 알. 스퀴부 앤드 선즈, 엘.엘.씨. |
예정 사멸 리간드 1 (피디-엘1)에 대한 인간 모노클로날 항체
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
DE602006009834D1
(de)
|
2005-09-01 |
2009-11-26 |
Schering Corp |
Verwendung von il-23 und il-17-antagonisten zur behandlung von autoimmuner entzündlicher augenerkrankung
|
|
DK2046809T3
(en)
|
2006-07-19 |
2017-03-13 |
Univ Pennsylvania |
WSX-1 / IL-27 AS A TARGET OBJECTIVE FOR ANTI-INFLAMMATORY REACTIONS
|
|
CA2706425A1
(en)
|
2007-11-27 |
2009-06-04 |
Ablynx N.V. |
Method for obtaining polypeptide constructs comprising two or more single domain antibodies
|
|
US8168757B2
(en)
|
2008-03-12 |
2012-05-01 |
Merck Sharp & Dohme Corp. |
PD-1 binding proteins
|
|
US20110311550A1
(en)
*
|
2008-10-24 |
2011-12-22 |
The Scripps Research Institute |
Agents for hcv treatment
|
|
MX356367B
(es)
|
2008-12-09 |
2018-05-25 |
Genentech Inc |
Anticuerpos anti-pd-l1 y su uso para mejorar la funcion de celulas t.
|
|
WO2010118243A2
(en)
|
2009-04-08 |
2010-10-14 |
Genentech, Inc. |
Use of il-27 antagonists to treat lupus
|
|
GB201005063D0
(en)
|
2010-03-25 |
2010-05-12 |
Ucb Pharma Sa |
Biological products
|
|
UY33492A
(es)
|
2010-07-09 |
2012-01-31 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
CN105859889B
(zh)
|
2010-11-17 |
2020-01-07 |
中外制药株式会社 |
具有代替凝血因子viii的功能的功能的多特异性抗原结合分子
|
|
US20120201746A1
(en)
|
2010-12-22 |
2012-08-09 |
Abbott Laboratories |
Half immunoglobulin binding proteins and uses thereof
|
|
WO2012097238A2
(en)
|
2011-01-14 |
2012-07-19 |
Five Prime Therapeutics, Inc. |
Il-27 antagonists for treating inflammatory diseases
|
|
DK2714738T3
(en)
|
2011-05-24 |
2019-01-28 |
Zyngenia Inc |
MULTIVALENT AND MONOVALENT MULTISPECIFIC COMPLEXES AND THEIR APPLICATIONS
|
|
EP2729488A4
(en)
|
2011-07-06 |
2015-01-14 |
Medimmune Llc |
PROCESS FOR PREPARING MULTIMANT POLYPEPTIDES
|
|
US8790651B2
(en)
|
2011-07-21 |
2014-07-29 |
Zoetis Llc |
Interleukin-31 monoclonal antibody
|
|
WO2013059299A1
(en)
|
2011-10-17 |
2013-04-25 |
The Uab Research Foundation |
Antibodies for interferon subtypes and interferon/interferon receptor ternary complex and uses thereof
|
|
WO2013180200A1
(ja)
*
|
2012-05-30 |
2013-12-05 |
中外製薬株式会社 |
標的組織特異的抗原結合分子
|
|
JP6693872B2
(ja)
|
2013-07-25 |
2020-05-13 |
シトムクス セラピューティクス,インコーポレイティド |
多重特異性抗体、多重特異性活性化可能抗体、及びそれらの使用方法
|
|
US20160251440A1
(en)
|
2013-09-26 |
2016-09-01 |
Ablynx N.V. |
Bispecific nanobodies
|
|
CN122399016A
(zh)
|
2014-03-15 |
2026-07-17 |
诺华股份有限公司 |
使用嵌合抗原受体治疗癌症
|
|
IL300029A
(en)
|
2014-05-16 |
2023-03-01 |
Baylor Res Institute |
Methods and preparations for the treatment of autoimmune and inflammatory conditions
|
|
AU2015366284B2
(en)
|
2014-12-19 |
2021-07-22 |
Ablynx N.V. |
Cysteine linked nanobody dimers
|
|
HRP20191800T1
(hr)
|
2015-05-13 |
2019-12-27 |
Ablynx N.V. |
Polipeptidi koji regrutiraju t stanice koji se temelje na tcr alfa/beta reaktivnosti
|
|
EP3297672B1
(en)
|
2015-05-21 |
2021-09-01 |
Harpoon Therapeutics, Inc. |
Trispecific binding proteins and methods of use
|
|
PT3328894T
(pt)
|
2015-08-06 |
2019-02-13 |
Agency Science Tech & Res |
Anticorpos de cadeia comum gama/il2rbeta
|
|
CN107400166A
(zh)
|
2016-05-19 |
2017-11-28 |
苏州康宁杰瑞生物科技有限公司 |
针对ctla4的单域抗体及其衍生蛋白
|
|
US12447213B2
(en)
|
2016-10-07 |
2025-10-21 |
The Broad Institute, Inc. |
Modulation of novel immune checkpoint targets
|
|
CN110312736B
(zh)
*
|
2017-01-23 |
2023-05-09 |
苏州康宁杰瑞生物科技有限公司 |
Pd-l1结合多肽或化合物
|
|
SG11201908929VA
(en)
|
2017-03-31 |
2019-10-30 |
Univ Leland Stanford Junior |
Synthekine compositions and methods of use
|
|
EP3634465A4
(en)
|
2017-05-25 |
2021-01-20 |
The Broad Institute, Inc. |
LYMPHOCYTE ANTIGEN CD5 SIMILAR (CD5L) MONOMER, HOMODIMER AND INTERLEUKIN 12B (P40) HETERODIMER ANTAGONISTS AND METHOD OF USE THEREOF
|
|
IL321812A
(en)
|
2017-08-03 |
2025-08-01 |
Synthorx Inc |
Cytokine complexes for the treatment of autoimmune diseases
|
|
SG11202005146VA
(en)
*
|
2017-12-18 |
2020-06-29 |
Regeneron Pharma |
Bispecific antigen binding molecules that bind leptin receptor and/or gp130, and methods of use thereof
|
|
SG11202004158QA
(en)
|
2017-12-28 |
2020-06-29 |
Nanjing Legend Biotech Co Ltd |
Single-domain antibodies and variants thereof against tigit
|
|
TW202010757A
(zh)
|
2018-04-11 |
2020-03-16 |
美商英伊布里克斯公司 |
具有經受限cd3結合的多重特異性多肽構築體以及相關方法及用途
|
|
IL279367B2
(en)
|
2018-06-13 |
2026-05-01 |
Novartis Ag |
BCMA chimeric antigen receptors and their uses
|
|
WO2019242632A1
(en)
|
2018-06-19 |
2019-12-26 |
1§1Nanjing Legend Biotech Co., Ltd. |
Engineered cells and uses thereof
|
|
AU2019321490B2
(en)
|
2018-08-13 |
2025-09-04 |
Inhibrx Biosciences, Inc. |
Ox40-binding polypeptides and uses thereof
|
|
WO2020144164A1
(en)
|
2019-01-07 |
2020-07-16 |
Bactolife Aps |
Pathogen binding proteins
|
|
GB201903767D0
(en)
|
2019-03-19 |
2019-05-01 |
Quadrucept Bio Ltd |
Multimers, tetramers & octamers
|
|
CN111018985B
(zh)
|
2019-12-06 |
2021-06-18 |
南京融捷康生物科技有限公司 |
针对牛血清白蛋白bsa的单域抗体的应用
|
|
KR20230061392A
(ko)
|
2020-08-05 |
2023-05-08 |
신테카인, 인크. |
수용체 쌍형성과 관련된 조성물 및 방법
|
|
KR102846963B1
(ko)
|
2020-08-05 |
2025-08-18 |
신테카인, 인크. |
IL27Rα 결합 분자 및 사용 방법
|
|
EP4192502A4
(en)
|
2020-08-05 |
2024-10-09 |
Synthekine, Inc. |
Compositions and methods related to il27 receptor binding
|